Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA
Dr. Sweeney’s institution received funding from the Bill & Melinda Gates Foundation. He owns stock in Multerra Bio. Dr. Khatri received support for article research from the National Institutes of Health and Bill & Melinda Gates Foundation. Drs. Sweeney and Khatri are co-founders and stockholders of Inflammatix, which has a commercial interest in the Sepsis MetaScore.